Home RxNorm 1739887 atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral Tablet [Phenohytro] Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 1739887
RxNorm name atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral Tablet [Phenohytro]
Display name PHENOHYTRO (Oral Pill)
Full name atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral Tablet [Phenohytro]
Term type SBD
Status Active
Strength 0.0194-0.1037-16.2-0.0065 mg
Dose form Tab
Route Oral Pill
Updated 2026-10-22 07:00:00 RxNorm Status History#
Status Active
Source RXNORM
Current YES
Release start 042016
Active start 042016
Multiple ingredient YES
Branded YES Ingredients And Strength# Derived Ingredient Concepts# FDA NDC Products And Packages# Package NDC, Product NDC, Name table Package NDC Product NDC Name Labeler Application 75826-118-00 75826-118 Phenohytro PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE Winder Laboratories, LLC 75826-118-10 75826-118 Phenohytro PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE Winder Laboratories, LLC
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 2 matching rows.
NDC11, Source, Active table NDC11 Source Active 75826011800 rxnav_ndcs yes 75826011810 rxnav_ndcs yes
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective 27c8baac-f8ce-46d8-8a0f-ff769dd408d9 Phenohytro 0.0194 MG / 0.1037 MG / 16.2 MG / 0.0065 MG Oral Tablet [PSN] · atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral Tablet [Phenohytro] [SBD] · Phenohytro (atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine HBr 0.0065 MG) Oral Tablet [SY] 3 5 Phenohytro™ (Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide) Tablets Rx Only 20191227
Recently Linked DailyMed Labels# Set ID, Title, Manufacturer table Set ID Title Manufacturer Effective 27c8baac-f8ce-46d8-8a0f-ff769dd408d9 Phenohytro™ (Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide) Tablets Rx Only Winder Laboratories, LLC 20191227
Drug Classes# Source, Class ID, Class table Source Class ID Class Type Relationship Drug concept ATC S01FA Anticholinergics ATC1-4 scopolamine ATC S01FA Anticholinergics ATC1-4 atropine ATC N03AA Barbiturates and derivatives ATC1-4 phenobarbital ATC A03BA Belladonna alkaloids, tertiary amines ATC1-4 atropine ATC A03BA Belladonna alkaloids, tertiary amines ATC1-4 hyoscyamine ATC A04AD Other antiemetics ATC1-4 scopolamine ATC N05CM Other hypnotics and sedatives ATC1-4 scopolamine FDASPL N0000175574 Anticholinergic EPC has_epc scopolamine FDASPL N0000175574 Anticholinergic EPC has_epc atropine FDASPL N0000175700 Cholinergic Muscarinic Antagonist EPC has_epc atropine FDASPL N0000175370 Cholinergic Antagonists MOA has_moa atropine FDASPL N0000175370 Cholinergic Antagonists MOA has_moa scopolamine FDASPL N0000000125 Cholinergic Muscarinic Antagonists MOA has_moa atropine MEDRT D001285 Atropine CHEM has_ingredient atropine MEDRT D001285 Atropine CHEM has_ingredient atropine sulfate MEDRT D064692 Hyoscyamine CHEM has_ingredient hyoscyamine MEDRT D064692 Hyoscyamine CHEM has_ingredient hyoscyamine sulfate MEDRT D010634 Phenobarbital CHEM has_ingredient phenobarbital MEDRT D012601 Scopolamine CHEM has_ingredient scopolamine MEDRT D012601 Scopolamine CHEM has_ingredient scopolamine hydrobromide MEDRT D000014 Abnormalities, Drug-Induced DISEASE may_treat hyoscyamine sulfate MEDRT D000014 Abnormalities, Drug-Induced DISEASE may_treat hyoscyamine MEDRT D000402 Airway Obstruction DISEASE ci_with phenobarbital MEDRT D000647 Amnesia DISEASE induces scopolamine MEDRT D000647 Amnesia DISEASE induces scopolamine hydrobromide MEDRT D001249 Asthma DISEASE ci_with atropine MEDRT D001249 Asthma DISEASE ci_with atropine sulfate MEDRT D001919 Bradycardia DISEASE may_treat atropine sulfate MEDRT D001919 Bradycardia DISEASE may_treat atropine MEDRT D003085 Colic DISEASE may_treat hyoscyamine MEDRT D003085 Colic DISEASE may_treat hyoscyamine sulfate MEDRT D003093 Colitis, Ulcerative DISEASE ci_with hyoscyamine MEDRT D003093 Colitis, Ulcerative DISEASE ci_with hyoscyamine sulfate MEDRT D003093 Colitis, Ulcerative DISEASE ci_with atropine MEDRT D003093 Colitis, Ulcerative DISEASE ci_with atropine sulfate MEDRT D003108 Colonic Diseases DISEASE may_treat scopolamine MEDRT D003108 Colonic Diseases DISEASE may_treat scopolamine hydrobromide MEDRT D004238 Diverticulitis DISEASE may_treat scopolamine hydrobromide MEDRT D004238 Diverticulitis DISEASE may_treat scopolamine MEDRT D004342 Drug Hypersensitivity DISEASE ci_with atropine sulfate MEDRT D004342 Drug Hypersensitivity DISEASE ci_with phenobarbital MEDRT D004342 Drug Hypersensitivity DISEASE ci_with scopolamine MEDRT D004342 Drug Hypersensitivity DISEASE ci_with scopolamine hydrobromide MEDRT D004342 Drug Hypersensitivity DISEASE ci_with hyoscyamine MEDRT D004342 Drug Hypersensitivity DISEASE ci_with hyoscyamine sulfate MEDRT D004342 Drug Hypersensitivity DISEASE ci_with atropine MEDRT D064420 Drug-Related Side Effects and Adverse Reactions DISEASE may_treat atropine MEDRT D064420 Drug-Related Side Effects and Adverse Reactions DISEASE may_treat atropine sulfate MEDRT D004403 Dysentery DISEASE may_treat scopolamine MEDRT D004403 Dysentery DISEASE may_treat scopolamine hydrobromide MEDRT D004828 Epilepsies, Partial DISEASE may_treat phenobarbital MEDRT D020936 Epilepsy, Benign Neonatal DISEASE may_treat phenobarbital MEDRT D004830 Epilepsy, Tonic-Clonic DISEASE may_treat phenobarbital MEDRT D005158 Facial Paralysis DISEASE may_treat scopolamine MEDRT D005158 Facial Paralysis DISEASE may_treat scopolamine hydrobromide MEDRT D018589 Gastroparesis DISEASE induces hyoscyamine sulfate MEDRT D018589 Gastroparesis DISEASE induces hyoscyamine MEDRT D005901 Glaucoma DISEASE ci_with hyoscyamine MEDRT D005901 Glaucoma DISEASE ci_with hyoscyamine sulfate MEDRT D015812 Glaucoma, Angle-Closure DISEASE ci_with atropine MEDRT D015812 Glaucoma, Angle-Closure DISEASE ci_with scopolamine hydrobromide MEDRT D015812 Glaucoma, Angle-Closure DISEASE ci_with scopolamine MEDRT D015812 Glaucoma, Angle-Closure DISEASE ci_with atropine sulfate MEDRT D006323 Heart Arrest DISEASE may_treat atropine sulfate MEDRT D006323 Heart Arrest DISEASE may_treat atropine MEDRT D006327 Heart Block DISEASE ci_with atropine MEDRT D006327 Heart Block DISEASE ci_with atropine sulfate MEDRT D006470 Hemorrhage DISEASE ci_with scopolamine MEDRT D006470 Hemorrhage DISEASE ci_with scopolamine hydrobromide MEDRT D006932 Hyperbilirubinemia DISEASE may_treat phenobarbital MEDRT D006945 Hyperhidrosis DISEASE may_treat hyoscyamine sulfate MEDRT D006945 Hyperhidrosis DISEASE may_treat hyoscyamine MEDRT D007077 Ileal Diseases DISEASE ci_with hyoscyamine sulfate MEDRT D007077 Ileal Diseases DISEASE ci_with hyoscyamine MEDRT D007415 Intestinal Obstruction DISEASE ci_with hyoscyamine sulfate MEDRT D007415 Intestinal Obstruction DISEASE ci_with atropine MEDRT D007415 Intestinal Obstruction DISEASE ci_with hyoscyamine MEDRT D007415 Intestinal Obstruction DISEASE ci_with scopolamine MEDRT D007415 Intestinal Obstruction DISEASE ci_with atropine sulfate MEDRT D007415 Intestinal Obstruction DISEASE ci_with scopolamine hydrobromide MEDRT D007431 Intraoperative Complications DISEASE may_treat hyoscyamine sulfate MEDRT D007431 Intraoperative Complications DISEASE may_treat hyoscyamine MEDRT D015863 Iridocyclitis DISEASE may_treat scopolamine MEDRT D015863 Iridocyclitis DISEASE may_treat scopolamine hydrobromide MEDRT D007499 Iris Diseases DISEASE ci_with atropine MEDRT D007499 Iris Diseases DISEASE ci_with atropine sulfate MEDRT D043183 Irritable Bowel Syndrome DISEASE may_treat hyoscyamine MEDRT D043183 Irritable Bowel Syndrome DISEASE may_treat hyoscyamine sulfate MEDRT D007674 Kidney Diseases DISEASE ci_with atropine MEDRT D007674 Kidney Diseases DISEASE ci_with atropine sulfate MEDRT D007905 Lens Diseases DISEASE ci_with atropine sulfate MEDRT D007905 Lens Diseases DISEASE ci_with atropine MEDRT D008107 Liver Diseases DISEASE ci_with atropine MEDRT D008107 Liver Diseases DISEASE ci_with atropine sulfate MEDRT D017093 Liver Failure DISEASE ci_with phenobarbital MEDRT D008532 Megacolon, Toxic DISEASE ci_with atropine sulfate MEDRT D008532 Megacolon, Toxic DISEASE ci_with hyoscyamine sulfate MEDRT D008532 Megacolon, Toxic DISEASE ci_with atropine MEDRT D008532 Megacolon, Toxic DISEASE ci_with hyoscyamine MEDRT D009041 Motion Sickness DISEASE may_prevent scopolamine hydrobromide MEDRT D009041 Motion Sickness DISEASE may_prevent scopolamine MEDRT D009127 Muscle Rigidity DISEASE may_treat hyoscyamine sulfate MEDRT D009127 Muscle Rigidity DISEASE may_treat hyoscyamine MEDRT D009157 Myasthenia Gravis DISEASE ci_with atropine MEDRT D009157 Myasthenia Gravis DISEASE ci_with hyoscyamine sulfate MEDRT D009157 Myasthenia Gravis DISEASE ci_with scopolamine MEDRT D009157 Myasthenia Gravis DISEASE ci_with atropine sulfate MEDRT D009157 Myasthenia Gravis DISEASE ci_with hyoscyamine MEDRT D009157 Myasthenia Gravis DISEASE ci_with scopolamine hydrobromide MEDRT D015878 Mydriasis DISEASE induces scopolamine hydrobromide MEDRT D015878 Mydriasis DISEASE induces scopolamine MEDRT D015878 Mydriasis DISEASE induces atropine MEDRT D015878 Mydriasis DISEASE induces atropine sulfate MEDRT D017202 Myocardial Ischemia DISEASE ci_with hyoscyamine MEDRT D017202 Myocardial Ischemia DISEASE ci_with hyoscyamine sulfate MEDRT D009325 Nausea DISEASE may_prevent scopolamine hydrobromide MEDRT D009325 Nausea DISEASE may_prevent scopolamine MEDRT D010301 Parkinson Disease, Postencephalitic DISEASE may_treat scopolamine MEDRT D010301 Parkinson Disease, Postencephalitic DISEASE may_treat scopolamine hydrobromide MEDRT D010437 Peptic Ulcer DISEASE may_treat hyoscyamine sulfate
Properties# Category, Property, Value table Category Property Value ATTRIBUTES AVAILABLE_STRENGTH 0.0194 MG / 0.1037 MG / 16.2 MG / 0.0065 MG ATTRIBUTES GENERAL_CARDINALITY MULTI ATTRIBUTES HUMAN_DRUG US ATTRIBUTES RXNAV_HUMAN_DRUG US ATTRIBUTES SCHEDULE 4 NAMES Prescribable Synonym Phenohytro 0.0194 MG / 0.1037 MG / 16.2 MG / 0.0065 MG Oral Tablet NAMES Tallman Synonym atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / PHENobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral Tablet [Phenohytro] NAMES Tallman Synonym Phenohytro (atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / PHENobarbital 16.2 MG / scopolamine HBr 0.0065 MG) Oral Tablet SOURCES Source Gold Standard Alchemy SOURCES Source Metathesaurus FDA Structured Product Labels SOURCES Source Micromedex RED BOOK SOURCES Source Multum MediSource Lexicon